DBE TECHNOLOGY, BGR and GRS are developing a methodology to demonstrate the safety of a repository for high-level waste and spent fuel (HLW/SF) in clays according to the requirements of the German regulating body. In particular, these requirements prescribe that the barrier effect of host rocks must not be compromised by a thermal impact resulting from HLW/SF emplacement. To substantiate and quantify this requirement, we carried out a literature survey of research on thermally-induced changes on clay properties. Effects thus compiled can be divided into thermo-hydro-mechanical and chemical-biological-mineralogical effects and were analysed with regard to their relevance to the integrity of clay host rocks. This analysis identified one effect of major influence within each group: thermal expansion and compaction as well as results of microbial activities. Importantly, it further revealed that a moderate temperature increase above 100°C cannot be expected to compromise the integrity of the geological barrier according to the current knowledge state. Evidence is presented in this paper that temperature increases up to 150°C can actually contribute to an improved performance of a radioactive waste repository by increasing the consolidation of the clay and sterilizing the repository's near-field to depress the deteriorative microbial effects. A quantitative temperature criterion for thermal impact of HLW/SF on clay host rocks is accordingly proposed.

Diet-induced obesity is associated with low-grade inflammation, which, in most cases, leads to the development of metabolic disorders, primarily insulin resistance and type 2 diabetes. Although prior studies have implicated the adipose tissue as being primarily responsible for obesity-associated inflammation, the latest discoveries have correlated impairments in intestinal immune homeostasis and the mucosal barrier with increased activation of the inflammatory pathways and the development of insulin resistance. Therefore, it is essential to define the mechanisms underlying the obesity-associated gut alterations to develop therapies to prevent and treat obesity and its associated diseases. Flavonoids appear to be promising candidates among the natural preventive treatments that have been identified to date. They have been shown to protect against several diseases, including CVD and various cancers. Furthermore, they have clear anti-inflammatory properties, which have primarily been evaluated in non-intestinal models. At present, a growing body of evidence suggests that flavonoids could exert a protective role against obesity-associated pathologies by modulating inflammatory-related cellular events in the intestine and/or the composition of the microbiota populations. The present paper will review the literature to date that has described the protective effects of flavonoids on intestinal inflammation, barrier integrity and gut microbiota in studies conducted using in vivo and in vitro models.